About

Compounded
Tirzepatide Tablets

In stock

Rx Required

FSA/HSA eligible

As low as $259/month*

Compounded oral Tirzepatide is a once-daily GLP-1 and GIP medication taken as a dissolving tablet. It is designed to curb appetite and reduce cravings, aiding in weight management.

1 Month
$ 379 Per Month

Billed & Shipped monthly

3 Month
$ 329 Per Month

Billed & Shipped every 3mo

6 Month
$ 309 Per Month

Billed every 6mo & Shipped every 3 mo

1 Year
$ 259 Per Month
Best Value

Billed every 12mo & Shipped every 3 mo

1 Month
$ 379 Per Month
3 Month
$ 329 Per Month
6 Month
$ 309 Per Month
1 Year
$ 259 Per Month
Best Value

Excellent

review

352 reviews on

Affordable care you can actually stick with

We built Agave to make clinician-guided weight loss support more accessible without surprise fees or confusing pricing. Get started online, get reviewed by a licensed provider, and receive medication shipped fast if approved.

Why Tirzepatide?

Tirzepatide works with two key metabolic pathways (GLP-1 + GIP) to support appetite regulation. For many patients, that can make it easier to eat less, reduce cravings, and stay consistent over time.

triz_tablet

Appetite support that feels manageable

Helps you feel full sooner and may reduce food noise, making it easier to stay consistent day to day and reach your weight loss goals.

Craving and portion control support

Designed to support healthier eating patterns without relying on extreme restriction.

right_img

Metabolic health benefits

GLP-1 therapies have been associated with broader cardiometabolic benefits in certain groups. Your provider will review what’s appropriate for you.

triz_tablet
• Appetite support that feels manageable
Helps you feel full sooner and may reduce food noise, making it easier to stay consistent day to day and reach your weight loss goals.
• Craving and portion control support
Designed to support healthier eating patterns without relying on extreme restriction.
• Metabolic health benefits
GLP-1 therapies have been associated with broader cardiometabolic benefits in certain groups. Your provider will review what’s appropriate for you.

Studies show

an average weight loss of

27.1 lbs

in the first six months

Based on self reported data from 160 of our members on weekly GLP- 1 injections, when combined with diet and exercise.

Experience

an average weight loss of

14.9%

within
a year

in the first six months

Based on self reported data from 160 of our members on weekly GLP- 1 injections, when combined with diet and exercise.

skinnyrx

Tirzepatide has been shown to improve blood sugar control and lower diabetes risk. GLP-1 medications have also been found to help protect the heart. They lower the risk of cardiovascular complications, like stroke and heart attack, by up to 14 percent in those with obesity and diabetes.

You're in good hands

Frequently Asked
Questions

How do I get started?

The first step is scheduling a consultation. Contact us here.

Your plan includes provider review, medication (if approved), and shipping. Any additional services will be shown before purchase.

Most orders ship quickly after approval; overnight options may be available depending on location.

This is a compounded medication prepared by a compounding pharmacy; compounded drugs are not FDA-approved.

  • We partner with U.S.-based pharmacies that operate under applicable federal and state requirements and are licensed to dispense prescription medication. Many compounding pharmacies also follow additional quality and safety standards (e.g., sterility and potency testing).
  • Important: Compounded medications are prepared by a compounding pharmacy and are not FDA-approved. The FDA regulates drug manufacturing and oversees certain pharmacy standards, but it does not “approve” compounded medications the way it approves brand-name drugs.
  • No—you won’t be charged for medication if a licensed provider determines you’re not eligible. If any evaluation or administrative fee applies, you’ll see it clearly before you submit payment.
  • If you’re not approved, we’ll let you know why (when appropriate) and what next steps may look like.
  • Possibly—but it depends on your medical history, prior dose, how recently you used it, and how you tolerated it. During your intake, you can share your previous prescription details (dose, dates, pharmacy, and any side effects).
  • A licensed provider will review everything and recommend a safe starting dose. For safety, some patients may need to restart at a lower dose if there’s been a gap or if prior documentation can’t be confirmed.
  • After you sign up, here’s what to expect:
  1. Complete your intake (medical history, goals, current meds)
  2. Provider review — a licensed clinician evaluates eligibility and determines an appropriate plan/dose
  3. If approved, we process your order through our partner pharmacy
  4. Shipping + tracking — medication is shipped discreetly (often quickly after approval)
  5. Ongoing check-ins — quick follow-ups to monitor progress, side effects, and refill timing
    If you’re not a candidate, we’ll let you know and explain next steps when appropriate.
  • If you are pregnant, breastfeeding, or trying to become pregnant, let us know during intake. In general, GLP-1 medications are not recommended in pregnancy, and your provider may advise stopping treatment and/or choosing a different approach.
  • If you become pregnant while taking treatment, contact your provider right away so they can guide next steps safely.

Most individuals notice changes within the first few weeks, with consistent weight loss occurring over several months. However, it’s important to note that a variety of factors play a role in the time it takes to start seeing results in your weight loss journey. These include:

  • Age
  • Weight
  • Lifestyle habits
  • Overall health
  • Medical history
  • Current caloric intake
  • Physical activity
  • Other medications that are taken during treatment.

Some patients may see changes in body weight and A1C levels sooner than others, keep in mind that your results may vary.

Semaglutide and Tirzepatide are prescribed weight loss medications that are administered under the supervision of a healthcare professional. It begins with an initial consultation to determine whether you are a good candidate for one of these innovative weight loss solutions.

These treatments offer multiple benefits for supporting weight loss by suppressing appetite, reducing calorie intake, regulating insulin and glucose production, and providing additional advantages that work best when combined with a low-calorie diet and routine physical activity.

Both Semaglutide and Tirzepatide are given as once-weekly injections. We will guide you on how to self-administer them or offer the option to receive injections in the clinic. Patients who feel comfortable with self-injections are advised to rotate injection sites between the thighs, the upper arms, and the abdomen to avoid soreness.

While the injections help regulate appetite, they work best when combined with healthy eating and regular exercise. We will offer guidance on making lifestyle changes that enhance the treatment. Diet and routine physical activity are both critical for ensuring that you receive the maximum benefits from your Semaglutide or Tirzepatide injections to reach and maintain your ideal weight for the future.

If you miss a dose, contact us for advice on when to take your next injection. Staying consistent with the schedule is key for the best results.

States We Serve

Alaska – (AK)
Arizona – (AZ)
Arkansas – (AR)
California – (CA)
Colorado – (CO)
Connecticut – (CT)
Delaware – (DE)
Florida – (FL)
Georgia – (GA)
Hawaii – (HI)
Idaho – (ID)
Illinois – (IL)
Indiana – (IN)
Iowa – (IA)
Kansas – (KS)

Kentucky – (KY)
Louisiana – (LA)
Maine – (ME)
Maryland – (MD)
Massachusetts – (MA)
Michigan – (MI)
Minnesota – (MN)
Mississippi – (MS)
Missouri – (MO)
Montana – (MT)
Nebraska – (NE)
Nevada – (NV)
New Hampshire – (NH)
New Jersey – (NJ)
New Mexico – (NM)

North Carolina – (NC)
North Dakota – (ND)
Ohio – (OH)
Oklahoma – (OK)
Oregon – (OR)
Pennsylvania – (PA)
Rhode Island – (RI)
South Carolina – (SC)
South Dakota – (SD)
Tennessee – (TN)
Texas – (TX)
Utah